Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).
about
Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Study protocol for a multicent ...... cute Kidney Injury (STOP-AKI).
@en
Study protocol for a multicent ...... cute Kidney Injury (STOP-AKI).
@nl
type
label
Study protocol for a multicent ...... cute Kidney Injury (STOP-AKI).
@en
Study protocol for a multicent ...... cute Kidney Injury (STOP-AKI).
@nl
prefLabel
Study protocol for a multicent ...... cute Kidney Injury (STOP-AKI).
@en
Study protocol for a multicent ...... cute Kidney Injury (STOP-AKI).
@nl
P2093
P2860
P921
P1433
P1476
Study protocol for a multicent ...... Acute Kidney Injury (STOP-AKI)
@en
P2093
Esther Peters
Jacques Arend
John A Kellum
Jürgen Hummel
Michael Joannidis
Peter Pickkers
Ravindra L Mehta
P2860
P304
P356
10.1136/BMJOPEN-2016-012371
P577
2016-09-27T00:00:00Z